Patents by Inventor Seon Young Kim
Seon Young Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250171857Abstract: The present disclosure relates to a novel thyroid nodule diagnostic biomarker and use thereof, and more specifically to an mRNA biomarker or a combination of mRNA biomarkers that are capable of diagnosing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) among thyroid nodules with high accuracy and sensitivity compared to benign and malignant tumors. In the present disclosure, it was confirmed that the expression levels of OCLN, ZNF423, LYG1 and AQP5 are associated with the onset or aggravation of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Accordingly, the present disclosure provides OCLN, ZNF423, LYG1 and AQP5 genes as diagnostic biomarkers for non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).Type: ApplicationFiled: November 25, 2024Publication date: May 29, 2025Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Chan Kwon JUNG, Seon Young KIM, Jong-Lyul PARK, So-Yeon LEE
-
Patent number: 12249363Abstract: Disclosed herein is a method for controlling a refresh period of an extension memory pool. The method includes collecting information about each of preset unit DRAM cell sets of an extension memory pool, setting an initial refresh period for each of the DRAM cell sets, and adjusting the refresh period based on the information collected from the DRAM cell sets.Type: GrantFiled: November 4, 2022Date of Patent: March 11, 2025Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTEInventor: Seon-Young Kim
-
Publication number: 20240095070Abstract: Disclosed herein is a method for task scheduling for an accelerator pool. The method includes receiving state information of an accelerator in the accelerator pool, generating a list of accelerators capable of being assigned a task based on the state information, calculating the amount of additional power that is to be consumed when the task is assigned to each of the accelerators in the list, and assigning the task to an accelerator in consideration of the calculated amount of additional power to be consumed and conductive heat between accelerators.Type: ApplicationFiled: September 5, 2023Publication date: March 21, 2024Inventor: Seon-Young KIM
-
Publication number: 20230395404Abstract: A semiconductor package manufacturing apparatus is provided, which comprises a pin holder including a plurality of through holes, a plurality of ejector pins corresponding to the plurality of through holes, a first pin disk including a first protrusion pattern having a first arrangement configured to adjust heights of the plurality of ejector pins, a second pin disk including a second protrusion pattern having a second arrangement configured to adjust the heights of the plurality of ejector pins, and a controller configured to select at least a portion of the plurality of ejector pins to protrude toward an upper portion of the pin holder by selecting one of the first and second pin disks.Type: ApplicationFiled: April 19, 2023Publication date: December 7, 2023Applicant: Samsung Electronics Co., Ltd.Inventors: Woo Ram MYUNG, Dae Ung PARK, Oh Chul KWON, Seon Young KIM, Yun-Sik YOO, Jun Ho CHO
-
Publication number: 20230238044Abstract: Disclosed herein is a method for controlling a refresh period of an extension memory pool. The method includes collecting information about each of preset unit DRAM cell sets of an extension memory pool, setting an initial refresh period for each of the DRAM cell sets, and adjusting the refresh period based on the information collected from the DRAM cell sets.Type: ApplicationFiled: November 4, 2022Publication date: July 27, 2023Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTEInventor: Seon-Young KIM
-
Publication number: 20220160058Abstract: The present disclosure relates to a mask having improved capability of blocking harmful substances, the mask including: a mask main body including at least one main body sheet; and an earring unit which is formed on both side surfaces of the mask main body, and including a coating layer which is formed on at least one surface of the main body sheet and comprises a TiO2-based nonphotocatalyst that is activated without irradiation of the solar light to decompose the harmful substances, wherein the nonphotocatalyst comprises: titanium dioxide (TiO2) having a band gap of 3.0 to 3.2 eV; and a transition metal doped with the titanium dioxide, and generates electrons through a spontaneous reaction by making Gibbs free energy change values into negative numbers.Type: ApplicationFiled: December 3, 2020Publication date: May 26, 2022Inventor: Seon-Young KIM
-
Patent number: 10253309Abstract: The present invention relates to an apparatus for separating fine particles using magnetophoresis, and to a method for separating fine particles using same, and particularly, to an apparatus for separating fine particles using magnetophoresis, which includes a fine, patterned magnetic structure capable of quickly and efficiently separating even particles that are weakly magnetized and coupled to fine particles, and to a method for separating fine particles using same.Type: GrantFiled: August 19, 2011Date of Patent: April 9, 2019Assignee: INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Ki Ho Han, Hwan Yong Lee, Song I Han, Seon Young Kim, In Hak Choi
-
Patent number: 9075066Abstract: The present invention relates to a biomarker for gastric cancer, CST1 (cysteine proteinase inhibitor, type 2 family), DCC1 (Defective in sister chromatid cohesion homolog 1), IFITM1 (interferon induced transmembrane protein 1) or MELK (maternal embryonic leucine zipper kinase). More particularly, the present invention relates to a diagnostic composition for gastric cancer comprising an agent measuring the expression level of CST1, DCC1, IFITM1 or MELK, a kit comprising the composition, a method for detecting the marker, and a method for screening a therapeutic agent for gastric cancer using the marker.Type: GrantFiled: April 21, 2009Date of Patent: July 7, 2015Assignee: Korea Research Institute of Bioscience and BiotechnologyInventors: Hee Gu Lee, Eun Young Song, Min Ah Kang, Jong Tae Kim, Jae Wha Kim, Young Il Yeom, Seon Young Kim, Kyung Chan Park
-
Publication number: 20130190200Abstract: The present invention relates to a single nucleotide polymorphism (SNP) for predicting the sensitivity to an anticancer targeted therapeutic formulation, a polynucleotide containing the same, and a method for predicting the sensitivity to an anticancer targeted therapeutic formulation. According to the present invention, it is possible to predict the sensitivity of each individual to a certain anticancer targeted therapeutic formulation, using a small amount of a sample taken from a patient and thus to select a most suitable targeted therapeutic formulation over the entire duration of treatment for the patient.Type: ApplicationFiled: December 8, 2010Publication date: July 25, 2013Applicants: Korea Research Institute of Bioscience and Biotechnology, The ASAN FoundationInventors: Jin Cheon Kim, Yong Sung Kim, Seon Young Kim, Dong Hyung Cho
-
Publication number: 20130189755Abstract: The present invention relates to an apparatus for separating fine particles using magnetophoresis, and to a method for separating fine particles using same, and particularly, to an apparatus for separating fine particles using magnetophoresis, which includes a fine, patterned magnetic structure capable of quickly and efficiently separating even particles that are weakly magnetized and coupled to fine particles, and to a method for separating fine particles using same.Type: ApplicationFiled: August 19, 2011Publication date: July 25, 2013Applicant: INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Ki Ho Han, Hwan Yong Lee, Song l Han, Seon Young Kim, In Hak Choi
-
Patent number: 8486905Abstract: Provided are a composition for diagnosing cancer or screening an anticancer drug comprising an FLJ25416 gene or an antibody directed to a protein expressed from the FLJ25416 gene, a composition for treating cancer comprising an inhibitor of the gene or an inhibitor of the protein expressed from the gene and a pharmaceutically acceptable carrier, and a kit for diagnosing cancer comprising at least one of the FLJ25416 gene and the protein expressed from the FLJ25416 gene. The FLJ25416 gene is expressed at high level in specific cancer cells, and induces an increase in proliferation rate of normal cells. The expression of the gene is suppressed, which results in an inhibitory effect on cancer cell growth. Thus, the FLJ25416 gene can be used as a target gene for diagnosis or treatment of cancer.Type: GrantFiled: December 5, 2008Date of Patent: July 16, 2013Assignees: Korea Research Institute of Bioscience and Biotechnology, St. Pharm Co., Ltd.Inventors: Misun Won, Kyung-Sook Chung, Young-Joo Kim, Shin-Jung Choi, Young Il Yeom, Seon-Young Kim, Kyung Bin Song, Hee Gu Lee, Eun Young Song, Young Ho Kim, Ho Kyung Chun, Chae-Ok Yun, Moon Hee Kim, Kyeong-Eun Jung, Sun-Jung Cho
-
Patent number: 8314082Abstract: The present disclosure relates to bisphenyl compounds that are useful for inhibiting the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like.Type: GrantFiled: May 31, 2011Date of Patent: November 20, 2012Assignee: Industrial Cooperation Foundation Chonbuk National UniversityInventors: Uh-Hyun Kim, Ho-Jeong Kwon, Mie-Jae Im, Seon-Young Kim, Kwang-Hyun Park, So-Young Rah, Tae-Sik Nam, Byung-Ju Kim, Gul Rukhsana
-
Patent number: 8283129Abstract: Disclosed herein is a colorectal cancer marker for diagnosing colorectal cancer based on ESM-I overexpression in tissues, cells or body fluids of colorectal cancer patients. Disclosed also is the use of the colorectal cancer marker in the development of therapeutic agents for cancer and in the diagnosis and treatment of colorectal cancer.Type: GrantFiled: November 23, 2007Date of Patent: October 9, 2012Assignee: Korea Research Institute of Bioscience and BiotechnologyInventors: Eun Young Song, Mi Young Park, Hyang Sin Lee, Hee Gu Lee, Jae Wha Kim, In Seong Choe, Min A Kang, Mi Sun Won, Kyung-Sook Chung, Young Ho Kim, Ho Kyung Chun, Young Il Yeom, Seon-Young Kim
-
Publication number: 20110281826Abstract: The present disclosure relates to bisphenyl compounds that are useful for inhibiting the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like.Type: ApplicationFiled: May 31, 2011Publication date: November 17, 2011Inventors: Uh-Hyun Kim, Ho-Jeong Kwon, Mie-Jae Im, Seon-Young Kim, Kwang-Hyun Park, So-Young Rah, Tae-Sik Nam, Byung-Ju Kim, Gul Rukhsana
-
Publication number: 20110251097Abstract: The present invention relates to a composition for diagnosing colon cancer. The composition comprises at least one marker for measuring an mRNA or protein expression level of at least one gene specific for colon cancer. It can screen the genes which are overexpressed specifically only in colon cancer tissues or blood. The present invention can quantitatively analyze both the mRNA expression levels of the genes and the expression levels of the proteins encoded by the gene at the same time, thereby diagnosing colon caner of an early stage with a high level of reliability.Type: ApplicationFiled: April 20, 2009Publication date: October 13, 2011Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYInventors: Eun Young Song, Hee Gu Lee, Young Il Yeom, Jae Wha Kim, Na Young Ji, Kyung-Sook Chung, Misun Won, Seon-Young Kim, Joo Heon Kim, Young Ho Kim, Ho Kyung Chun
-
Publication number: 20110008370Abstract: Provided are a composition for diagnosing cancer or screening an anticancer drug comprising an FLJ25416 gene or an antibody directed to a protein expressed from the FLJ25416 gene, a composition for treating cancer comprising an inhibitor of the gene or an inhibitor of the protein expressed from the gene and a pharmaceutically acceptable carrier, and a kit for diagnosing cancer comprising at least one of the FLJ25416 gene and the protein expressed from the FLJ25416 gene. The FLJ25416 gene is expressed at high level in specific cancer cells, and induces an increase in proliferation rate of normal cells. The expression of the gene is suppressed, which results in an inhibitory effect on cancer cell growth. Thus, the FLJ25416 gene can be used as a target gene for diagnosis or treatment of cancer.Type: ApplicationFiled: December 5, 2008Publication date: January 13, 2011Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHInventors: Misun Won, Kyung-Sook Chung, Young-Joo Kim, Shin-Jung Choi, Young Il Yeom, Seon-Young Kim, Kyung Bin Song, Hee Gu Lee, Eun Young Song, Young Ho Kim, Ho Kyung Chun, Chae-Ok Yun, Moon Hee Kim, Kyeong-Eun Jung, Sun-Jung Cho
-
Publication number: 20100248244Abstract: Disclosed herein is a colorectal cancer marker for diagnosing colorectal cancer based on ESM-I overexpression in tissues, cells or body fluids of colorectal cancer patients. Disclosed also is the use of the colorectal cancer marker in the development of therapeutic agents for cancer and in the diagnosis and treatment of colorectal cancer.Type: ApplicationFiled: November 23, 2007Publication date: September 30, 2010Applicant: Korea Research Institute of Bioscience and BiotechnologyInventors: Eun Young Song, Mi Young Park, Hyang Sin Lee, Hee Gu Lee, Jae Wha Kim, In Seong Choe, Min A. Kang, Mi Sun Won, Kyung Sook Chung, Young Ho Kim, Ho Kyung Chun, Young Il Yeom, Seon-Young Kim
-
Publication number: 20100075334Abstract: The present application describes a method of diagnosing gastric cancer or a stage in the progression of the cancer in a subject comprising assaying for loss of expression of a marker gene such as POPDC3, CCDC67, LRRC3B, PRKD1, CYP1B1, LIMS2, DCBLD2, LOC149351, ADCY8, BACH2, ALOX5, TCF4, CXXC4, CAMK2N2, EMX1, KCNK9, NCAM2, AMPD3, NOG, SP6, LOC100128675, or CHSY3, or a combination thereof.Type: ApplicationFiled: April 15, 2008Publication date: March 25, 2010Inventors: Yong Sung Kim, Seung Moo Noh, Hyang Sook Yoo, Jeong Hwan Kim, Mi Rang Kim, Hay Ran Jang, Kyu Sang Song, June Sik Cho, Seon-Young Kim, Hyun Yong Jeong
-
Publication number: 20100069619Abstract: The present disclosure relates to bisphenyl compounds that are useful for inhibit the ADP-ribosyl cyclase (ADPR-cyclase). More particularly, the disclosed compounds can be used for treatment and prevention of hypertension, hypertensive cardiac hypertrophy, diabetes, and diabetic nephropathy, in which pathogenesis ADPR-cyclase is involved. The compounds and compositions of the invention can be used for treatment and prevention of cardiovascular disease and related disease states, particularly, hypertension or diabetes related disorders, such as, hypertensive cardiac hypertrophy, diabetic nephropathy, and the like.Type: ApplicationFiled: December 28, 2007Publication date: March 18, 2010Inventors: Uh-Hyun Kim, Ho-Jeong Kwon, Mie-Jae Im, Seon-Young Kim, Kwang-Hyun Park, So-Young Rah, Tae-Sik Nam, Byung-Ju Kim, Gul Rukhsana
-
Patent number: 7275375Abstract: A regenerator includes a casing including a connection channel for making a high temperature part and a cooling part communicate with each other; and a thermal energy storage material inserted in the connection channel of the casing and made of an aramid fiber which stores/radiates heat of a working fluid flowing through the connection channel. A cryocooler includes the regenerator. Accordingly, regeneration performance of storing heat included in the working fluid and transmitting the stored heat to a working fluid is improved, and simultaneously a weight is decreased, thereby minimizing abrasion of components.Type: GrantFiled: October 18, 2004Date of Patent: October 2, 2007Assignee: LG Electronics Inc.Inventor: Seon-Young Kim